1.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUGEN-SU101.035, CDR0000067275, SUGEN-990711, NCT00004071
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUGEN-SU101.015, CDR0000066226, MSKCC-98020, UCLA-HSPC-980105201, NCT00003293
|
|
3.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUGEN-SU101.004, NCI-V96-1091
|
|
4.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUGEN-SU101.009, NYU-9828
|
|
5.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUGEN-SU101.010
|
|
6.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: SUGEN-SU101.021, CDR0000066904, MSKCC-98111, NCI-G99-1506, NCT00003775
|
|
7.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-95019, NCI-V95-0663
|
|
8.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUGEN-SU101.002, NCI-V96-1090
|
|
9.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUGEN-SU101.003, NCI-V96-1092
|
|
10.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 3 to 21
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: NCI-97-C-0087E, SUGEN-NCI-97-C-0087
|
|
11.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-HSPC-980901101B, SUGEN-SU101.032A, NCI-G99-1550
|
Mobile | Español
